Addex Therapeutics Ltd (SWX:ADXN)
0.0452
+0.0002 (0.44%)
May 13, 2026, 3:30 PM CET
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
86.50K CHF
Profits / Employee
-3.36M CHF
Market Cap
5.25M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2 | -21 | -91.30% |
| Dec 31, 2023 | 23 | -1 | -4.17% |
| Dec 31, 2022 | 24 | -2 | -7.69% |
| Dec 31, 2021 | 26 | -1 | -3.70% |
| Dec 31, 2020 | 27 | 8 | 42.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bachem Holding AG | 2,595 |
| Idorsia | 487 |
| Basilea Pharmaceutica AG | 189 |
| Molecular Partners AG | 134 |
| Santhera Pharmaceuticals Holding AG | 94 |
| BioVersys AG | 33 |
| Newron Pharmaceuticals | 27 |
| Xlife Sciences AG | 17 |
Addex Therapeutics News
- 12 days ago - Q4 2025 Addex Therapeutics Ltd Earnings Call Transcript - GuruFocus
- 13 days ago - Addex Therapeutics Earnings Call Transcript: H2 2025 - Transcripts
- 13 days ago - Addex Reports Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 14 days ago - Addex Therapeutics (ADXN) Reveals Promising Preclinical Results for Chronic Cough Treatment - GuruFocus
- 14 days ago - Addex Therapeutics announces GABAB PAM candidate data - TheFly
- 14 days ago - Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model - GlobeNewsWire
- 20 days ago - Addex Therapeutics (ADXN) Sees Progress with Neurosterix's Clinical Study - GuruFocus
- 20 days ago - Addex Therapeutics says spin-out company to complete NTX-253 study in Q2 - TheFly